BR112017014379A2 - composição para o tratamento de infecções causadas pelo acaro demodex spp - Google Patents

composição para o tratamento de infecções causadas pelo acaro demodex spp

Info

Publication number
BR112017014379A2
BR112017014379A2 BR112017014379-8A BR112017014379A BR112017014379A2 BR 112017014379 A2 BR112017014379 A2 BR 112017014379A2 BR 112017014379 A BR112017014379 A BR 112017014379A BR 112017014379 A2 BR112017014379 A2 BR 112017014379A2
Authority
BR
Brazil
Prior art keywords
treatment
demodex spp
composition
mite
present
Prior art date
Application number
BR112017014379-8A
Other languages
English (en)
Other versions
BR112017014379B1 (pt
Inventor
Egea Bermejo Eduardo
Garavito De Egea Gloria
Abello Llanos Raimundo
Luz Mendoza Meza Dary
Lizarazo Carreno Martha
Escaff Jaraba Luis
Carlos Escaff Sales Luis
Original Assignee
Procaps S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procaps S.A. filed Critical Procaps S.A.
Publication of BR112017014379A2 publication Critical patent/BR112017014379A2/pt
Publication of BR112017014379B1 publication Critical patent/BR112017014379B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9062—Alpinia, e.g. red ginger or galangal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

a presente invenção tem por objeto composições de óleos essenciais para o tratamento de infecções causadas por o ácaro demodex spp. particularmente, a presente invenção é dirigida a uma composição para o tratamento de infecções oftálmicas blefarite e para o tratamento de pessoas com uma condição conhecida como demodicose produzida pelo ácaro demodex spp e cujos sintomas incluem irritação dos olhos incluindo olhos secos, prurido, diminuição da visão e madarose ou perda de cílios. outras utilizações da composição da presente invenção, sem ser limitativo, são todas as doenças causadas pelo ácaro demodex spp nos seres humanos. de acordo com o invento o efeito acaricida da mesma é porque desidrata os ácaros e os ovos por efeito lipolítico de modo que solubiliza as membranas lipídicas da estrutura anatómica do animal e assim remove-lo.
BR112017014379-8A 2014-12-30 2014-12-30 composição para o tratamento de infecções causadas pelo acaro demodex spp BR112017014379B1 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2014/067414 WO2016108070A1 (es) 2014-12-30 2014-12-30 Composiciones para el tratamiento de infecciones producidas por el acaro demodex spp

Publications (2)

Publication Number Publication Date
BR112017014379A2 true BR112017014379A2 (pt) 2018-03-20
BR112017014379B1 BR112017014379B1 (pt) 2021-03-02

Family

ID=56284351

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017014379-8A BR112017014379B1 (pt) 2014-12-30 2014-12-30 composição para o tratamento de infecções causadas pelo acaro demodex spp

Country Status (7)

Country Link
US (1) US10357526B2 (pt)
EP (1) EP3251682B1 (pt)
JP (1) JP6553206B2 (pt)
BR (1) BR112017014379B1 (pt)
CR (1) CR20170346A (pt)
MX (1) MX2017008787A (pt)
WO (1) WO2016108070A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019142943A (ja) * 2019-04-26 2019-08-29 プロキャプス ソシエダ アノニマ ニキビダニ属種（ｄｅｍｏｄｅｘ ｓｐｐ）のダニによって引き起こされる感染症を、治療するための組成物（ｃｏｍｐｏｓｉｔｉｏｎｓ ｆｏｒ ｔｈｅ ｔｒｅａｔｍｅｎｔ ｏｆ ｉｎｆｅｃｔｉｏｎｓ ｃａｕｓｅｄ ｂｙ ｍｉｔｅ ｄｅｍｏｄｅｘ ｓｐｐ）
SE544843C2 (en) * 2019-12-23 2022-12-13 Oriflame Cosmetics Ag Plant extracts for treatment of rosacea
US20220323472A1 (en) * 2021-03-30 2022-10-13 Frank Anthony SPALLITTA Anti-parasitic compounds for the treatment and prevention of viral diseases

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003252774A (ja) * 2002-02-26 2003-09-10 Kenji Hirano デモデクスの殺生用薬剤、化粧剤および殺生方法
US20050058672A1 (en) * 2003-09-14 2005-03-17 Bioderm Research Baby Care Skin Protectant Compositions for Diaper Rash
US7320797B2 (en) * 2003-08-29 2008-01-22 Bioderm Research Antiaging cosmetic delivery systems
US20050215635A1 (en) * 2004-03-08 2005-09-29 Rafi M Mohamed Diarylheptanoid compounds and uses thereof
US20090214676A1 (en) * 2005-04-30 2009-08-27 Tissuetech, Inc. Method for treating ocular demodex
KR100668878B1 (ko) * 2005-07-29 2007-01-12 강민용 발모제 조성물, 발모용 피부 외용제 조성물 및 발모제조성물, 발모용 피부 외용제 조성물의 제조방법
US8895080B2 (en) * 2008-06-20 2014-11-25 Ocusoft, Inc. Compositions and kits for ocular treatment
JP5952302B2 (ja) * 2010-12-29 2016-07-13 ニチャミン、ルイス・ディー 眼の治療のための方法及びキット
PL223972B1 (pl) * 2013-04-11 2016-11-30 Ofta Spółka Z Ograniczoną Odpowiedzialnością Olejek szałwiowy do zastosowania w leczeniu i profilaktyce stanów zapalnych wywołanych przez nużeńce, zwłaszcza zapalenia brzegów powiek oraz kompozycja farmaceutyczna zawierająca olejek szałwiowy do zastosowania w leczeniu i profilaktyce stanów zapalnych wywołanych przez nużeńce, zwłaszcza zapalenia brzegów powiek

Also Published As

Publication number Publication date
EP3251682A1 (en) 2017-12-06
EP3251682B1 (en) 2024-02-21
EP3251682A4 (en) 2018-12-12
MX2017008787A (es) 2018-03-15
WO2016108070A1 (es) 2016-07-07
US20180353560A1 (en) 2018-12-13
US10357526B2 (en) 2019-07-23
JP6553206B2 (ja) 2019-07-31
BR112017014379B1 (pt) 2021-03-02
JP2018501318A (ja) 2018-01-18
CR20170346A (es) 2017-11-07

Similar Documents

Publication Publication Date Title
SV2016005206A (es) Derivados novedosos de amino pirimidina
CL2018001089A1 (es) Sales de valbenazina y polimorfos de las mismas.
BR112019008458A2 (pt) 1,2,4-triazolonas 2,4,5-trisubstituídas.
CL2016002812A1 (es) Uso de ácido 3-2,3,5,6-tetrafluoro-3-trifluorometoxi-bifenil-4-ilcarbamoil-tiofeno-2-carboxílico para preparar un medicamento útil para tratar una enfermedad ocular que es uveítis, ojo seco o causada por un adenovirus composición formulación.
CO2019008684A2 (es) 2-heteroaril-3-oxo-2,3-dihidropiridazin-4-carboxamidas para el tratamiento del cancer
BR112013018920A2 (pt) composições de nanopartículas, formulações destas e seus usos
BR112014008789A2 (pt) prevenção e tratamento de condições oculares
BR112017023161A2 (pt) composições de ácido obeticólico e métodos de uso
MX2019007587A (es) Composicion oftalmica para el tratamiento de la enfermedad del ojo seco.
BR112015007778A2 (pt) profármacos neutralizantes de vegf para o tratamento de condições oculares
CU20190101A7 (es) Imidazopirimidinas diazabicíclicas sustituidas
BR112017014332A2 (pt) métodos de tratamento de doenças retinianas
CL2017002825A1 (es) Formulaciones de tpp1 y métodos para tratar la enfermedad de cln2
UY35276A (es) Nuevos compuestos que inhiben la actividad de Lp-PLA2
BR112015017929A8 (pt) di-hidropirimidinonas bicíclicas substituídas, composição farmacêutica que os compreende e uso
BR112019006463A2 (pt) composição oral de canabinoides extraídos e métodos de uso da mesma
BR112014010376A2 (pt) medicamento para o tratamento de doença do olho anterior que compreende rebamipida e um agente de retenção de lágrima
BR112015021334A2 (pt) formulações oculares para entrega de droga ao segmento posterior do olho
BR112018067946A2 (pt) formulações tópicas contendo ciclosporina e usos das mesmas
BR112017007428A2 (pt) composições de éster de ácido graxo e ácidos graxos autocomnizantes e suas utilizações no tratamento de estados da doença
ECSP11010956A (es) Compuestos enlazados con azufre para el tratamiento de enfermedades y trastornos oftalmicos
BR112017022755A2 (pt) formulações de glucopiranosil lipídeo a e alérgeno a amendoim para administração sublingual
MX2016015211A (es) Formulaciones topicas y usos de las mismas.
IL273531A (en) Ophthalmic preparations containing latanoprost for use in the treatment of eye diseases
CY1124538T1 (el) Χρηση prg4 για τη βελτιωση της δυναμικης οπτικης οξυτητας και εκτροπων υψηλοτερης ταξης

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/12/2014, OBSERVADAS AS CONDICOES LEGAIS.